Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-30 @ 9:09 PM
Study NCT ID:
NCT01896232
Status:
COMPLETED
Last Update Posted:
2019-07-18
First Post:
2013-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2014-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-08
First Submit QC Date:
None
Study First Post Date:
2013-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-07
Results First Submit QC Date:
None
Results First Post Date:
2017-02-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-10-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-07-08
Last Update Post Date:
2019-07-18
Last Update Post Date Type:
ACTUAL